Roble, Belko & Company, Inc - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 785 filers reported holding GLAXOSMITHKLINE PLC in Q1 2018. The put-call ratio across all filers is 1.37 and the average weighting 0.3%.

Quarter-by-quarter ownership
Roble, Belko & Company, Inc ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q1 2022$37,000
-2.6%
8570.0%0.01%0.0%
Q4 2021$38,000
+15.2%
8570.0%0.01%0.0%
Q3 2021$33,000
-2.9%
8570.0%0.01%
-12.5%
Q2 2021$34,000
+9.7%
8570.0%0.01%
+14.3%
Q1 2021$31,000
-3.1%
8570.0%0.01%
-12.5%
Q4 2020$32,0000.0%8570.0%0.01%
-11.1%
Q3 2020$32,000
-8.6%
8570.0%0.01%
-10.0%
Q2 2020$35,000
+9.4%
8570.0%0.01%0.0%
Q1 2020$32,000
-20.0%
8570.0%0.01%
-9.1%
Q4 2019$40,000
+8.1%
8570.0%0.01%0.0%
Q3 2019$37,000
-44.8%
857
-48.6%
0.01%
-47.6%
Q2 2019$67,000
-4.3%
1,6660.0%0.02%
-12.5%
Q1 2019$70,000
+9.4%
1,6660.0%0.02%
-4.0%
Q4 2018$64,000
-4.5%
1,6660.0%0.02%
+4.2%
Q3 2018$67,0000.0%1,6660.0%0.02%
-7.7%
Q2 2018$67,000
+3.1%
1,6660.0%0.03%
+4.0%
Q1 2018$65,000
+10.2%
1,6660.0%0.02%
+4.2%
Q4 2017$59,000
-13.2%
1,6660.0%0.02%
-20.0%
Q3 2017$68,000
-5.6%
1,6660.0%0.03%
-14.3%
Q2 2017$72,000
-25.8%
1,666
-27.7%
0.04%
-27.1%
Q1 2017$97,000
+9.0%
2,3040.0%0.05%
+2.1%
Q4 2016$89,000
-10.1%
2,3040.0%0.05%
-11.3%
Q3 2016$99,000
-1.0%
2,3040.0%0.05%
-3.6%
Q2 2016$100,000
-14.5%
2,304
-19.9%
0.06%
-16.7%
Q1 2016$117,000
+30.0%
2,875
+28.5%
0.07%
+22.2%
Q4 2015$90,000
+4.7%
2,2370.0%0.05%
+1.9%
Q3 2015$86,000
-7.5%
2,2370.0%0.05%
-1.9%
Q2 2015$93,000
-9.7%
2,2370.0%0.05%
-10.0%
Q1 2015$103,0002,2370.06%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q1 2018
NameSharesValueWeighting ↓
SENZAR ASSET MANAGEMENT, LLC 668,200$30,717,0009.01%
Camber Capital Management LP 1,200,000$55,164,0005.18%
Camber Capital Management LP 1,000,000$45,970,0004.32%
Gary Goldberg Planning Services Inc 178,496$8,205,0003.41%
Hamlin Capital Management, LLC 1,217,870$55,985,0003.36%
Winch Advisory Services, LLC 109,101$5,015,0003.22%
NORTHROAD CAPITAL MANAGEMENT LLC 151,701$6,974,0002.69%
Reynders McVeigh Capital Management, LLC 296,118$13,613,0002.59%
SALEM CAPITAL MANAGEMENT INC 120,520$5,540,0002.58%
Keystone Financial Planning, Inc. 74,338$3,417,0002.58%
View complete list of GLAXOSMITHKLINE PLC shareholders